moa of glp-1 agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Recent updates on GLP-1 agonists:

GLP-1 Complete Next-generation weight management solution to reduce food cravings, promote feeling full more quickly, and keep you feeling satisfied longer by activating multiple GLP-1 receptors

Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof

A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight loss was associated with a marked drop in drinking over 10 months, with his AUDIT score falling from 27 to 7 and alcohol use dropping from about 15 drinks per week to half a beer per month

All doses of FDA-approved Wegovy, the most widely prescribed and studied GLP-1 for weight loss, are now accessible to patients of select telehealth providers...